Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Oct;87(19):7370–7374. doi: 10.1073/pnas.87.19.7370

Worldwide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQ beta chain.

J S Dorman 1, R E LaPorte 1, R A Stone 1, M Trucco 1
PMCID: PMC54748  PMID: 2217170

Abstract

The presence of an amino acid other than aspartic acid at position 57 of the HLA-DQ beta chain (non-Asp-57) is highly associated with susceptibility to insulin-dependent diabetes mellitus (IDDM), whereas an aspartic acid at this position (Asp-57) appears to confer resistance to the disease. We hypothesize that the 30-fold difference in IDDM incidence across racial groups and countries is related to variability in the frequency of these alleles. Diabetic and nondiabetic individuals were evaluated in five populations, including those at low, moderate, and high risk. HLA-DQ beta genotype distributions among the IDDM case groups were markedly different (P less than 0.001), as were those among nondiabetic controls (P less than 0.001). Non-Asp-57 alleles were significantly associated with IDDM in all areas; population-specific odds ratios for non-Asp-57 homozygotes relative to Asp-57 homozygotes ranged from 14 to 111. Relative risk information from the case-control study and population incidence data were combined to estimate genotype-specific incidence rates for the Allegheny County, PA, Caucasians. These rates were used to predict the overall incidence rates in the remaining populations, which were within the 95% confidence intervals of the actual rates established from incidence registries. These results are consistent with the hypothesis that population variation in the distribution of non-Asp-57 alleles may explain much of the geographic variation in IDDM incidence.

Full text

PDF
7370

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awata T., Kuzuya T., Matsuda A., Iwamoto Y., Kanazawa Y., Okuyama M., Juji T. High frequency of aspartic acid at position 57 of HLA-DQ beta-chain in Japanese IDDM patients and nondiabetic subjects. Diabetes. 1990 Feb;39(2):266–269. doi: 10.2337/diab.39.2.266. [DOI] [PubMed] [Google Scholar]
  2. Bao M. Z., Wang J. X., Dorman J. S., Trucco M. HLA-DQ beta non-ASP-57 allele and incidence of diabetes in China and the USA. Lancet. 1989 Aug 26;2(8661):497–498. doi: 10.1016/s0140-6736(89)92102-8. [DOI] [PubMed] [Google Scholar]
  3. Barnett A. H., Eff C., Leslie R. D., Pyke D. A. Diabetes in identical twins. A study of 200 pairs. Diabetologia. 1981 Feb;20(2):87–93. doi: 10.1007/BF00262007. [DOI] [PubMed] [Google Scholar]
  4. Erlich H. A., Bugawan T. L., Scharf S., Nepom G. T., Tait B., Griffith R. L. HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes. 1990 Jan;39(1):96–103. doi: 10.2337/diacare.39.1.96. [DOI] [PubMed] [Google Scholar]
  5. Garrett T. P., Saper M. A., Bjorkman P. J., Strominger J. L., Wiley D. C. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature. 1989 Dec 7;342(6250):692–696. doi: 10.1038/342692a0. [DOI] [PubMed] [Google Scholar]
  6. Kwok W. W., Mickelson E., Masewicz S., Milner E. C., Hansen J., Nepom G. T. Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition. J Exp Med. 1990 Jan 1;171(1):85–95. doi: 10.1084/jem.171.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. LaPorte R. E., Fishbein H. A., Drash A. L., Kuller L. H., Schneider B. B., Orchard T. J., Wagener D. K. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) registry. The incidence of insulin-dependent diabetes mellitus in Allegheny County, Pennsylvania (1965-1976). Diabetes. 1981 Apr;30(4):279–284. doi: 10.2337/diab.30.4.279. [DOI] [PubMed] [Google Scholar]
  8. LaPorte R. E., Tajima N., Akerblom H. K., Berlin N., Brosseau J., Christy M., Drash A. L., Fishbein H., Green A., Hamman R. Geographic differences in the risk of insulin-dependent diabetes mellitus: the importance of registries. Diabetes Care. 1985 Sep-Oct;8 (Suppl 1):101–107. doi: 10.2337/diacare.8.1.s101. [DOI] [PubMed] [Google Scholar]
  9. Marrack P., Kappler J. The T cell receptor. Science. 1987 Nov 20;238(4830):1073–1079. doi: 10.1126/science.3317824. [DOI] [PubMed] [Google Scholar]
  10. Morel P. A., Dorman J. S., Todd J. A., McDevitt H. O., Trucco M. Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8111–8115. doi: 10.1073/pnas.85.21.8111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nikolić-Zugić J., Bevan M. J. Role of self-peptides in positively selecting the T-cell repertoire. Nature. 1990 Mar 1;344(6261):65–67. doi: 10.1038/344065a0. [DOI] [PubMed] [Google Scholar]
  12. Rewers M., LaPorte R. E., Walczak M., Dmochowski K., Bogaczynska E. Apparent epidemic of insulin-dependent diabetes mellitus in Midwestern Poland. Diabetes. 1987 Jan;36(1):106–113. doi: 10.2337/diab.36.1.106. [DOI] [PubMed] [Google Scholar]
  13. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet. 1987 Jan;40(1):1–14. [PMC free article] [PubMed] [Google Scholar]
  14. Rønningen K. S., Iwe T., Halstensen T. S., Spurkland A., Thorsby E. The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus. Hum Immunol. 1989 Nov;26(3):215–225. doi: 10.1016/0198-8859(89)90040-2. [DOI] [PubMed] [Google Scholar]
  15. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  16. Todd J. A., Bell J. I., McDevitt H. O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 1987 Oct 15;329(6140):599–604. doi: 10.1038/329599a0. [DOI] [PubMed] [Google Scholar]
  17. Todd J. A., Fukui Y., Kitagawa T., Sasazuki T. The A3 allele of the HLA-DQA1 locus is associated with susceptibility to type 1 diabetes in Japanese. Proc Natl Acad Sci U S A. 1990 Feb;87(3):1094–1098. doi: 10.1073/pnas.87.3.1094. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Todd J. A., Mijovic C., Fletcher J., Jenkins D., Bradwell A. R., Barnett A. H. Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature. 1989 Apr 13;338(6216):587–589. doi: 10.1038/338587a0. [DOI] [PubMed] [Google Scholar]
  19. Trucco G., Fritsch R., Giorda R., Trucco M. Rapid detection of IDDM susceptibility with HLA-DQ beta-alleles as markers. Diabetes. 1989 Dec;38(12):1617–1622. doi: 10.2337/diab.38.12.1617. [DOI] [PubMed] [Google Scholar]
  20. Trucco M., Dorman J. S. Immunogenetics of insulin-dependent diabetes mellitus in humans. Crit Rev Immunol. 1989;9(3):201–245. [PubMed] [Google Scholar]
  21. Yamagata K., Nakajima H., Hanafusa T., Noguchi T., Miyazaki A., Miyagawa J., Sada M., Amemiya H., Tanaka T., Kono N. Aspartic acid at position 57 of DQ beta chain does not protect against type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia. 1989 Oct;32(10):762–764. doi: 10.1007/BF00274539. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES